Weiqi Yao
- Molecular Biology
- Electrical and Electronic Engineering
- Genetics top 10%
- Surgery
- Pathology and Forensic Medicine
- Topics
- Mesenchymal stem cell research (6 papers)CAR-T cell therapy research (2 papers)COVID-19 Clinical Research Studies (2 papers)
- Cited by
- GeneticsCancer ResearchNephrology
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Weiqi Yao
17 papers receiving 511 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 180
- Electrical and Electronic Engineering 145
- Genetics 140
- Surgery 85
- Pathology and Forensic Medicine 65
Countries citing papers authored by Weiqi Yao
This map shows the geographic impact of Weiqi Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqi Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqi Yao more than expected).
Fields of papers citing papers by Weiqi Yao
This network shows the impact of papers produced by Weiqi Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqi Yao. The network helps show where Weiqi Yao may publish in the future.
Co-authorship network of co-authors of Weiqi Yao
This figure shows the co-authorship network connecting the top 25 collaborators of Weiqi Yao. A scholar is included among the top collaborators of Weiqi Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqi Yao. Weiqi Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 14 | |
| 6 | 16 | |
| 7 | 19 | |
| 8 | 18 | |
| 9 | 149 | |
| 10 | 22 | |
| 11 | 41 | |
| 12 | 18 | |
| 13 | 1 | |
| 14 | 106 | |
| 15 | 14 | |
| 16 | 32 | |
| 17 | Tissue factor is strongly expressed in pericarcinomatous tissue in patients with laryngeal carcinoma. | 4 |
| 18 | 58 | |
| 19 | 2 |
About Weiqi Yao
Weiqi Yao is a scholar working on Genetics, Hepatology and Otorhinolaryngology, having authored 19 papers that have together received 521 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (6 papers), CAR-T cell therapy research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Genetics (140 citations), Cancer Research (65 citations) and Nephrology (29 citations). Weiqi Yao has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Lei Shi, Jie Xu, Ingo Manke, Nan Chen, Yongjie Cao, Liang Zhan, Yu‐Feng Meng, Renjie Chen, Yanli Wang and Chao Yang. Their work appears in journals such as Blood, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.